The devastating infections that fungal pathogens cause in humans are underappreciated relative to viral, bacterial and parasitic diseases. In recent years, the contributions to virulence of reductive iron uptake, siderophore-mediated uptake and heme acquisition have been identified in the best studied and most lifethreatening fungal pathogens: Candida albicans, Cryptococcus neoformans and Aspergillus fumigatus. In particular, exciting new work illustrates the importance of iron acquisition from heme and hemoglobin in the virulence of pathogenic yeasts. However, the challenge of establishing how these fungi gain access to hemoglobin in blood and to other sources of heme remains to be fully addressed. Recent studies are also expanding our knowledge of iron uptake in less-well studied fungal pathogens, including dimorphic fungi where new information reveals an integration of iron acquisition with morphogenesis and cell-surface properties for adhesion to host cells. Overall, the accumulating information provides opportunities to exploit iron acquisition for antifungal therapy, and new work highlights the development of specific inhibitors of siderophore biosynthesis and metal chelators for therapeutic use alone or in conjunction with existing antifungal drugs. It is clear that iron-related therapies will need to be customized for specific diseases because the emerging view is that fungal pathogens use different combinations of strategies for iron acquisition in the varied niches of vertebrate hosts.
Introduction
Despite being an abundant metal on Earth, the bioavailability of iron in the environment is extremely limited due to its existence as insoluble ferric oxide. Microbial pathogens face an additional challenge to acquire iron and other key metals, such as zinc, manganese and copper, inside vertebrate hosts. 
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Fungal pathogens cause devastating diseases in humans, but have received far less attention than viral, bacterial and parasitic infections. [2] [3] [4] [5] This lack of appreciation is surprising given the high risk of fungal infections in people with HIV/AIDS or cancer, or those receiving organ transplants or immunomodulatory therapy. The most common fungal pathogen of humans is Candida albicans and this fungus, along with other Candida species, causes superficial mucosal infections as well as life-threatening systemic disease. 6 Additionally, the fungus Cryptococcus neoformans is a devastating agent of meningitis in HIV/AIDS patients with an estimated 1 million cases per year and over 600 000 deaths. 5, 7 Similarly, Aspergillus fumigatus and other Aspergillus species cause a range of diseases (aspergilloses) that include allergic bronchopulmonary, chronic pulmonary and invasive aspergillosis. 8 Given the serious threats posed by fungal pathogens, there is a pressing need for new approaches to treat infections, especially in the face of increasing resistance to an already limited number of antifungal drugs. 9 In this context, iron acquisition by fungi during host colonization presents a compelling target for new diagnostic and therapeutic approaches.
In this mini-review, we consider the major systems of iron acquisition in pathogenic fungi including reductive iron uptake, siderophore synthesis and transport, and mechanisms to use heme and hemoglobin, and we highlight recent advances that add depth to our understanding of iron acquisition. With reference to information from the model yeast Saccharomyces cerevisiae, we focus on the specific fungal pathogens C. albicans, Candida glabrata, C. neoformans and A. fumigatus, as illustrated in Fig. 1 . In particular, we emphasize the uptake functions for the pathogens that contribute to disease. Additionally, we include new studies for other species of pathogenic fungi where relevant information is available. We also address the iron sources that fungi exploit in vertebrate hosts, and much of this consideration involves exciting new work on fungal exploitation of heme and hemoglobin as abundant sources of iron. The key functions for iron acquisition that we discuss are listed in Table 1 . The information on known uptake strategies sets the stage for a consideration of approaches to exploit fungal iron uptake for diagnostic and therapeutic purposes. We refer readers to several recent reviews for additional considerations of iron homeostasis in fungi, including mechanisms of regulation and opportunities for therapy. [10] [11] [12] [13] [14] [15] [16] 
Reductive iron uptake: connections with virulence and dimorphism
The mechanisms of iron acquisition and homeostasis have been well studied in the model yeast S. cerevisiae, and this information provides a foundation for many of the studies in fungal pathogens. [17] [18] [19] S. cerevisiae primarily employs two different mechanisms for iron uptake that involve reductive and nonreductive systems. 17 Reductive iron uptake involves two sequential steps: (1) reduction of ferric iron to soluble ferrous iron by ferric reductases encoded by the FRE genes, FRE1 and FRE2, and; (2) re-oxidation to the ferric form by a multicopper ferroxidase (Fet3) coupled with transport into the cell by a permease (Ftr1). Nonreductive iron uptake involves the use of siderophorebound iron via specific transporters, although S. cerevisiae does not synthesize its own siderophores. 18 The fungal pathogens C. albicans, C. neoformans, and A. fumigatus also use a reductive iron uptake system involving conserved orthologs of the cell-surface ferric reductases, ferroxidases and iron permeases identified in S. cerevisiae. [19] [20] [21] [22] [23] The FRE reductases are integral membrane proteins that require heme, FAD and NADPH for activity. 24 At least 17 genes encoding putative ferric reductases have been identified in the C. albicans genome. Of these genes, the FRE10 and FRE7 genes encode highly active cell-surface ferric reductases and deletion of these genes results in decreased ferric iron uptake by the fungus. 21, 22, 25 More recent work on the Cfl1 ferric reductase from C. albicans expands our appreciation of the roles of these enzymes in fungal pathogens. Specifically, transcription of CFL1 is regulated in response to iron and copper, and deletion of the gene results in a remarkably large number of phenotypes. [26] [27] [28] These phenotypes include increased accumulation of cellular iron, altered cell wall architecture, loss of mitochondrial function, impaired filamentous growth, sensitivity to oxidative stress, and attenuated virulence in mouse model of systemic candidiasis. [26] [27] [28] Interestingly, a mutant lacking Cfl1 is not defective for iron acquisition, perhaps because of the observed compensatory upregulation of other ferric reductase genes in a cfl1 deletion mutant. 27 Cfl1 therefore
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More recent studies extended the analysis of reductive iron uptake to another clinically important Candida species, C. glabrata. This pathogen, which is actually more closely related to S. cerevisiae than to C. albicans, has emerged as the second leading cause of candidiasis after C. albicans. 45 An ortholog of the FTR1-encoded iron permease was identified in C. glabrata and found to be required for growth in iron-restricted medium. 37, 46 Additionally, deletion of FTR1 caused reduced colonization of the kidneys of infected mice suggesting that the iron permease is essential for the virulence of C. glabrata. 37 The same study also identified the C. glabrata ortholog of the Fet3 ferroxidase of S. cerevisiae. Similar to the ftr1 mutant, the C. glabrata strain lacking the FET3 ortholog also showed reduced colonization of the kidneys of mice, supporting the essentiality of high-affinity reductive iron uptake for virulence. 37 Interestingly, plasma membranelocalized Ftr1 moves to the vacuole in a Vps34-dependent manner upon exposure of C. glabrata to excess iron. 46 VPS34 encodes a phosphoinositide 3-kinase, and the C. glabrata mutant lacking the gene shows impaired iron homeostasis and a significant reduction of organ colonization in mice. The inability of a vps34 mutant to properly traffic Ftr1 as well as other virulence-related phenotypes (e.g., impaired biofilm formation) may contribute to the observed colonization defect.
Reductive iron uptake is also associated with morphogenesis in dimorphic or pleiomorphic fungal pathogens that can switch between yeast-like growth and hyphal or pseudohyphal growth. [47] [48] [49] The yeast to hyphal morphological transition has been well studied in C. albicans where the ability to switch contributes to virulence. 6 Emerging evidence indicates that iron acquisition is intertwined with morphological switching in some dimorphic fungi. For example, the reductive iron uptake system in C. albicans is coordinated with the function of the adhesin-like receptor protein, Als3, to facilitate iron acquisition from ferritin specifically during hyphal but not yeast growth. 47 A strong link between the expression of other adhesion proteins (e.g., MP65 and PGA62) and iron was also established in a study of the influence of iron on chromatin remodeling in C. albicans. 50 The connection between surface protein expression and iron may be a general feature of pathogenic yeasts because the EPA1 gene encoding the major adhesin in C. glabrata is also regulated by iron. 51 Very recently, Pasricha et al. reported a thorough characterization of the connections between cell morphology and both reductive iron uptake and siderophore-mediated uptake in the dimorphic pathogen Talaromyces marneffei. 49, 52 The pathogenic yeast phase of this fungus proliferates intracellularly in macrophages and causes disease in immunocompromised people, particularly in endemic areas such as Southeast Asia. Initial transcriptional profiling experiments revealed co-incident regulation of iron uptake functions with the temperature-mediated switch from hyphal (25 1C) to yeast (37 1C) growth. 52 Subsequent detailed experiments demonstrated that the T. marneffei fetC (ferroxidase) and ftrA (iron permease) genes have higher transcript levels both in response to iron limitation and in yeast cells compared to hyphae. In agreement, a deletion mutant lacking ftrA displayed reduced growth on low iron medium at 37 1C but not at 25 1C. 49 These results suggest that an additional iron uptake system may be active at 25 1C or that the yeast cells at 37 1C may have a higher demand for iron. Interestingly, the ftrA mutant did not display a defect in intracellular proliferation in macrophages suggesting that another uptake pathway is used in this context. As discussed below, the siderophore biosynthetic genes in T. marneffei were also characterized, and these genes also show interesting celltype regulation and contributions to growth. 49 3. Siderophore iron uptake: a potential drug target for some but not all fungal pathogens Along with reductive iron uptake, siderophore-mediated nonreductive iron uptake also contributes to iron acquisition in fungi. 14, 16 S. cerevisiae, C. neoformans and C. albicans do not synthesize their own siderophores, but can use exogenous siderophores (xenosiderophores) produced by other organisms. Early studies in S. cerevisiae again provide a model for uptake mechanisms for xenosiderophore-iron chelates, in this case via Arn/Sit transporters of the major facilitator superfamily. 24 These transporters, termed Arn1, Arn2/Taf1, Arn3/Sit1, and Arn4/Enb1, individually show specificity for different bacterial and fungal xenosiderophores such as enterobactin, ferrichrome, ferrichrome A, triacetylfusarine C, and ferrioxmaine B. 17, 24, 53 The siderophore bound Arn transporters are internalized and transported to late-endosomal compartments for vacuolar degradation to release the iron, as revealed by the trafficking of ferrioxamine B and ferrichrome-bound Arn3/Sit1 and Arn1 transporters, respectively. 53, 54 The trafficking of Sit1 to the vacuolar compartment depends on Rsp5-mediated ubiquitylation and the clathrin adaptor protein Gga2, and is regulated by the presence of the substrate ferrichrome B. 55, 56 A recent study by Kang et al. added further depth to the connection between intracellular trafficking and iron. 57 Specifically, it was found that the transcriptional activator Aft1 in S. cerevisiae, which responds to iron availability and regulates the expression of the FET3, FTR1 and ARN genes, interacts with the Arn3/Sit1 transporter and influences its ubiquitination and vacuole-dependent protein degradation. 56, 57 The Aft1-Arn3/Sit1 interaction illustrates the potential for additional sensing mechanisms that fine-tune the deployment of iron uptake strategies.
As indicated above, some pathogenic yeast exploit xenosiderophores produced by other microbes. C. albicans, for example, employs a Sit1/Arn1 transporter to use xenosiderophores such as ferricrocin, ferrichrysin, ferrirubin, coprogen and triacetylfusarine C. [58] [59] [60] Given that C. albicans is a human commensal, the fungus may encounter xenosiderophores from bacteria that co-inhabit mucosal or gastrointestinal niches. The Sit1/Arn1 transporter in C. albicans is required for efficient invasion of reconstituted epithelium as a model of the human oral mucosa, but does not contribute to virulence in a mouse model of systemic candidiasis. 60 Thus, siderophore-mediated iron uptake may not be important during bloodstream infection by C. albicans. 60 C. glabrata also possesses a Sit1 siderophore transporter, and Nevitt and Thiele investigated the influence of Sit1 on virulence by monitoring the survival of a sit1 mutant in a mouse macrophage cell line. 61 They observed reduced survival of the sit1 mutant within phagolysosomes of the infected macrophages compared to the wild-type strain. However, reduced survival of the mutant was only observed for fungal cells pre-treated with the xenosiderophore ferrichrome, a substrate of Sit1, and no difference was observed between the sit1 mutant and the wild-type strain without ferrichrome pre-treatment. C. neoformans also has a highly conserved transporter, Sit1, for the uptake of ferrioxamine B, and xenosiderophores may be important during proliferation of the fungus in the environment (i.e., in soil, bird excreta and in association with trees). 62 However, Sit1 in C. neoformans does not contribute to virulence in a mouse model of cryptococcosis. 62 Xenosiderophores are also important in the disease mucormycosis caused by Rhizopus oryzae and other fungi in the order Mucorales. 63 Mucormycosis is a threat to patients who are experiencing iron overload as a result of kidney dialysis and are receiving chelation therapy with the bacterial siderophore deferoxamine. The ability of R. oryzae to exploit deferoxamine to grow in the host, and the ability to use the siderophore, depends on cell surface binding proteins (Fob1 and Fob2) as well as the reductive uptake system. 63 Consistent with the latter requirement, defects in iron permease activity attenuate virulence in a deferoxamine-treated mouse model of mucormycosis. 63, 64 In contrast, the reductive uptake system encoded by CFT1 and CFO1 is not required for iron acquisition via the siderophore ferrioxamine B in C. neoformans. 33, 44 Siderophore-mediated iron uptake has been extensively studied in Aspergillus species including A. nidulans and A. fumigatus, and also in the dimorphic pathogen Histoplasma capsulatum. 15, 16, 36, 65, 66 Unlike C. albicans and C. neoformans, both the Aspergillus species and H. capsulatum synthesize different hydroxamate-type siderophores including ferricrocin, hydroxyferricrocin, fusarinine C, coprogen B and triacetylfusarinine C. 36, 65, 66 Extensive studies have characterized the genetics and regulation of siderophore production, and defined the role of siderophores in the virulence of A. fumigatus. 15, 16 In this pathogen, the sidA gene encoding L-ornithine-N 5 -monooxygenase is essential for siderophore biosynthesis and virulence. 36 Putative siderophore transporters have also been identified in both A. fumigatus and A. nidulans. [67] [68] [69] In a recent study, Park et al. described the roles of highly conserved orthologs of the S. cerevisiae Sit1 and Sit2 transporters in A. fumigatus and demonstrated their participation in the uptake of ferrichrome and ferrioxamine B. 67 However, these siderophore transporters did not contribute to the virulence of A. fumigatus in immunosuppressed mice. Another siderophore transporter, MirB, has also been characterized for A. fumigatus, but its contribution to virulence remains to be determined. 69 For H. capsulatum, a microarray analysis identified genes with increased expression under iron-poor conditions. 70 These genes encoded functions for siderophore synthesis (e.g., SID1 the ortholog of sidA) or transport (MFS1 and ABC1). Importantly, deletion of SID1 in H. capsulatum abolished siderophore biosynthesis as well as growth in bone marrow-derived macrophages and in mice, indicating that siderophore production is essential for the virulence of this fungus. 70 As introduced earlier, work in T. marneffei has provided interesting insights into the integration of iron acquisition with virulence-associated dimorphism. With regard to siderophore production, a characterization of the genetics and expression of siderophore biosynthesis revealed a suite of genes orthologous to most of those defined in A. fumigatus for the production of extracellular and intracellular siderophores. Interestingly, two orthologs of the A. fumigatus sidA gene (sidA and sidX) were found, and these genes make distinct contributions to growth in response to iron. 49 In particular, the growth of the sidA deletion mutant was not impaired but instead enhanced by iron limitation relative to the wild-type strain at 25 1C or 37 1C. 49 In contrast, the sidX deletion mutant grew poorly in low iron conditions at 25 1C or 37 1C, but behaved like wild type upon iron repletion. The sidA and sidX deletion mutants were not impaired for growth in macrophages. Finally, it was observed that the fetC gene for the multicopper ferroxidase was upregulated in the sidA and sidX deletion mutants indicating cross regulation between uptake pathways. 49 Taken together, these findings strengthen the view that iron acquisition is integrated with morphogenesis in some fungal pathogens, and they provide insights into the relative contributions of siderophore versus reductive uptake mechanisms for growth in phagocytic cells and for yeast versus hyphal cell types.
Heme and hemoglobin are important iron sources for pathogenic yeasts
Approximately 80% of the iron inside a mammalian host is bound to heme in hemoglobin (Hb) and other heme-containing proteins. In addition to hemoglobin, other host iron-containing proteins include lactoferrin (Lf), transferrin (Tf), haptoglobin, haemopexin, lipocalin-1 and lipocalin-2 (Lcn1/Lcn2). 71 Additionally, intracellular iron availability to microbes is also limited due to the sequestration of iron in transferrin and ferritin. 71, 72 Consequently, the ability of fungal pathogens of humans to obtain iron from different host iron-binding proteins to sustain growth and proliferation is a key determinant of the outcome of infection. In this regard, some fungal pathogens target heme and hemoglobin as key iron sources. For example, C. albicans has robust machinery to obtain iron from heme/hemoglobin. [73] [74] [75] This system is independent of the reductive and siderophore uptake mechanisms and depends on a conserved family of proteins (Rbt5, Rbt51/Pga10, Pga7 and Csa2) which contain the cysteinerich Common in Fungal Extracellular Membrane (CFEM) domain. [74] [75] [76] [77] [78] [79] Among these proteins, Rbt5 is a mannosylated plasma membrane-anchored protein that mediates heme uptake. 75 The paralog of RBT5, RBT51/PGA10, also confers the ability to use heme as a sole iron source in S. cerevisiae, and this finding provided a fruitful avenue to investigate heme and hemoglobin uptake. Specifically, a large-scale screen of the deletion library in S. cerevisiae expressing C. albicans RBT5 suggested that the Rbt5 protein is the GPI-anchored hemoglobin receptor that facilitates the endocytosis of hemoglobin into the vacuole. The functions identified in the screen implicated the involvement of acidification of the lumen of the late secretory pathway, a type I myosin and the activity of the ESCRT pathway in hemoglobin utilization in C. albicans. 76 A recent study also identified a role for another CFEM protein Pga7 in heme uptake in C. albicans. Pga7 was shown to cooperate with Rbt5 within the cell envelope for hemoglobin and heme utilization, and the mutant lacking PGA7 displayed a more significant growth deficiency than the rbt5 mutant in the medium with heme or hemoglobin as a sole iron source. 80 Furthermore, the pga7 mutant was attenuated for virulence in a mouse model of systemic infection suggesting that heme iron uptake contributes to C. albicans pathogenesis. 80 Another CFEM domain protein, Csa2, is required for robust growth on hemoglobin. Csa2 binds hemoglobin and may serve as a hemophore to deliver the protein to other CFEM proteins such as Pga7 and Rbt5. 77, 80, 81 In this context, a recent study presented the structural basis of heme-iron acquisition by Csa2, in C. albicans. 81 It was found that the CFEM domain in Csa2 adopts a novel six a-helical basket form with a flat hydrophobic platform on top to allow the attachment of a planer heme molecule. 81 A conserved aspartic residue in the CFEM helical basket serves as an axial ligand to confer the specificity of Fe 3+ heme binding. 81 This aspartic-heme-Fe axial ligand coordination in Csa2 partially resembles the tyrosine-heme-Fe axial ligand coordination of the bacterial hemophore, HasA, as described in the Gram-negative bacteria Serratia marcescens and Pseudomonas aeruginosa. 82, 83 The work on Csa2 further strengthens the model for heme-iron acquisition in C. albicans that involves removal of heme from hemoglobin by Csa2, transfer to envelope-anchored CFEM proteins Rbt5 and Pga7, and internalization by endocytosis ( Fig. 1) . 80 Other fungi also use heme and hemoglobin as iron sources in various capacities. 75 For example, the Candida species C. tropicalis and C. parapsilosis share the ability to use these iron sources with C. albicans, perhaps reflecting the fact that all three species belong to the same clade. However, other Candida species such as C. glabrata and C. krusei are unable to grow with heme and hemoglobin as iron sources. In addition, anti-Rbt51 antiserum reacted with cell lysates of C. tropicalis and C. parapsilosis, but not with lysates of C. glabrata and C. krusei, implying that the first two may possess an Rbt51 ortholog for heme uptake. 75 Other heme-related functions have been described in C. glabrata including a putative cell-surface bound CFEM domain-containing protein (Ccw14), a haemolysin-like protein (Mam3), and an intracellular haem oxygenase (Hmx1). 37 Both Ccw14 and Mam3 are involved in iron homeostasis and virulence for C. glabrata, although their role in the use of heme or hemoglobin requires further investigation. 37 CFEM proteins are important for hemoglobin use by other species including the dimorphic pathogens Paracoccidioides brasiliensis and P. lutzii. 84, 85 In these fungi, an ortholog of Rbt5 serves as a hemoglobin receptor and loss of the protein results in mutants with impaired survival in macrophages and in the spleens of infected mice. In contrast, deletion of three genes (cfmA-C) encoding CFEM-domain proteins in A. fumigatus did not reveal roles in heme uptake or biofilm formation, although cell wall defects were observed. 86 The lack of an involvement of CfmA-C in heme use is interesting given a recent detailed RNA-Seq analysis indicates that A. fumigatus expresses functions for iron homeostasis, secondary metabolism and detoxification to survive in blood, but does not grow. 87 This has been termed a ''just wait and see'' resting stage behavior for the fungus.
The use of heme as an iron source has also been described for C. neoformans. [88] [89] [90] In this fungus, a screen for genes required for growth on heme initially revealed a role for Vps23, a component of the ESCRT-I complex involved in endocytosis or regulation of iron acquisition. Vps23 was also required for virulence in a mouse inhalation model of cryptococcosis. 88 An additional study showed that other ESCRT proteins, specifically Vps22 (ESCRT-II) and Snf7/ Vps20 (ESCRT-III), also contribute to heme use in C. neoformans. 89 Similar to C. albicans, a putative hemophore, Cig1, has also been described in C. neoformans that is involved in heme binding, uptake and virulence. 90 The Cig1 protein does not contain a CFEM domain and therefore must interact with heme via a different mechanism than the C. albicans proteins. The reductive iron uptake system can mask the absence of Cig1 during colonization of mice because a cig1 mutant is as virulent as the wild-type strain, and a cig1cfo1 double mutant is more attenuated than a cfo1 mutant. These results contribute to the general view that multiple mechanisms of iron assimilation contribute to host colonization and that additional systems remain to be discovered in C. neoformans. 90 One outstanding issue concerns the access of C. neoformans to heme given that hemolytic activity has not been reported. The surface of Cryptococcal cells is unique among fungal pathogens in that the fungus elaborates a large polysaccharide capsule in response to a variety of signals including iron deprivation. 91 Interestingly, deletion of the VTC4 gene encoding a polyphosphate polymerase in C. neoformans resulted in impaired ability of the fungus to trigger blood coagulation in vitro. Although virulence was not attenuated for a vtc4 deletion mutant, cells of this strain did accumulate to a higher level than the wild type in the lungs of infected mice. Polyphosphate may therefore function in lung colonization or dissemination of the fungus from the lungs. A connection between the master iron regulator Cir1 in C. neoformans and the expression of functions for phosphate uptake and polyphosphate formation has been established. 92 It is therefore tempting to speculate that polyphosphate on the fungal cell surface might contribute to interactions with erythrocytes, and potentially to iron acquisition.
Targeting iron acquisition to augment antifungal therapy
The accumulating knowledge on the iron acquisition systems that contribute to fungal virulence promises to inform new approaches to diagnostics and therapy. In general, current strategies to target pathogen iron acquisition include the use of iron chelation therapy, siderophore-drug conjugates, inhibitors of uptake systems or biosynthetic enzymes, vaccines against surface uptake components, and immunological strategies to influence iron availability to intra and extracellular pathogens. [93] [94] [95] [96] [97] [98] [99] The approach of targeting biosynthetic enzymes for inhibitor development shows considerable promise for pathogens that deploy siderophores during host colonization. 97 Success in this area was recently demonstrated in a screen using an assay for the L-ornithine-N 5 -monooxygenase encoded by sidA in A. fumigatus. 100 The crystal structure of the enzyme has been determined and detailed biochemical studies led to the development of a fluorescence polarization binding assay involving a chromophore linked to ADP as a probe for active site binding of small molecules. 101, 102 A screen of 2320 compounds with the assay yielded celastrol as a specific SidA inhibitor, and follow up work showed that this compound at 50 mM inhibits the growth of A. fumigatus on defined minimal medium without iron and on blood agar. 100 As expected, the growth inhibition was rescued by siderophores. Interestingly, celastrol was previously found to have antifungal activity against phytopathogenic fungi. 103 The use of chelators for treatment of fungal infections also shows potential utility and recent studies illustrate the development of new chelators, the use of these molecules in combination with antifungal drugs and their use in treating topical fungal infections. [104] [105] [106] [107] In a search for new chelators, Helsel et al. screened a set of metal chelating agents for their ability to inhibit the growth of C. neoformans. 105 The tested compounds included general chelators, iron chelators including desferrioxamine B, and extracellular and intracellular molecules that bind copper. Interestingly, chelating compounds that bound iron or copper did not limit fungal growth in the assay conditions, but agents that acted to increase intracellular copper levels were inhibitory. The active molecules were ionophores and, importantly, were fungicidal for C. neoformans. The ability of combinations of iron chelators and antifungal drugs to inhibit the growth of C. neoformans, Cryptococcus gatti and S. cerevisiae has also been tested. 107 In particular, the chelators ethylenediamine tetraacetic acid, deferiprone, deferasirox, ciclopirox olamine and lactoferrin reduced the minimal inhibitory concentration of amphotericin B (AmB), a front line antifungal for cryptococcosis. The only combination that showed synergy was lactoferrin with AmB but iron supplementation did not ablate growth inhibition suggesting that another mechanism besides iron chelation may explain the lactoferrin contribution. Finally, recent work examined chelation as a topical treatment for corneal infections caused by A. fumigatus and another opportunistic fungal pathogen Fusarium oxysporum. 104 Iron availability as modulated by Fe-dextran and deferrioxamine treatment, and extracellular siderophore production, were shown to influence infection in a murine corneal infection model. Additionally, sequestration with the human siderophore-binding protein lipocalin-1 also reduced fungal growth during infection. Extracellular siderophore biosynthesis by A. fumigatus requires mevalonate as a precursor, and mutants unable to convert mevalonic acid to anhydromevalonyl CoA for incorporation (DsidH and DsidI) had reduced growth in infected tissue. 104 Together, these results led to a demonstration that topical treatment with statins that block HMG-CoA reductase activity for mevalonate production and the chelator deferiprone could protect corneal tissue from infection by A. fumigatus or F. oxysporum. 104 Overall, this study provides compelling support for combination treatment approaches, and the results hold particular promise for topical therapy of fungal infections on mucosal surfaces, skin and nails.
Conclusions
Our understanding of the mechanisms of iron acquisition systems and their contributions to virulence has expanded in the past three years for the best studied fungal pathogens A. fumigatus, C. albicans, C. glabrata and C. neoformans. Additionally, new insights are emerging for a broader range of pathogens including dimorphic species in the genera Talaromyces and Paracoccidioides. In particular, we gained insights into the roles of candidate ferric reductases at the cell surface and the complexities of the contributions of different enzymes in the face of redundancy. Redundancy is also a challenge in determining the potential contributions of multiple siderophore transporters in fungi that exploit xenosiderophores. Additional information from T. marneffei illustrates the integration of iron acquisition via reductive uptake and siderophores with virulence properties such as the temperature-dependent morphological switch that generates the pathogenic yeast cell type. A major recent accomplishment was the molecular characterization of the relay system of CFEM domain proteins for heme and hemoglobin use in C. albicans. This system will undoubtedly serve as a paradigm for many fungal pathogens, particularly among pathogenic yeasts, but perhaps not for A. fumigatus and other molds. Together, the accumulating information provides the foundation for therapeutic applications and recent studies support the value of targeting siderophore biosynthesis and metal chelation. It will be important to understand the specific strategies of each pathogen so that targeted interventions can be deployed. Many questions remain to be answered, particularly in the context of understanding the relative contributions of uptake systems for specific host iron sources. One challenge will be to fully understand the range of uptake systems when multiple mechanisms support growth in the host, and to develop the experimental models to understand niche-specific access to iron, particularly in the blood.
